Susanna Huh

Susanna Huh, MD MPH, currently serves as Vice President and Head of Late-Stage Clinical Development at Organon since July 2025. Prior to this role, Huh was Vice President and Head of Clinical Development at Ironwood Pharmaceuticals from 2022 to 2025, where significant achievements included obtaining sNDA approval for LINZESS in pediatric functional constipation in June 2023. Huh also held the position of Assistant Professor of Pediatrics at Harvard Medical School from 2011 to 2023, acting as a principal investigator on various significant grants. Huh directed the Growth and Nutrition Program at Boston Children's Hospital from 2009 to 2018, successfully transforming it into a profitable and recognized program. Additional experience includes serving as Senior Medical Director at Takeda from 2018 to 2022 and co-founding the COVID-19 Action Coalition, advocating for public health during the pandemic. Huh's educational background includes an MD from Western University, an MPH from Harvard T.H. Chan School of Public Health, and a BSc in Human Biology from the University of Toronto.